Cytokinetics, Inc. (CYTK)
63.48
+1.08
(+1.74%)
USD |
NASDAQ |
Mar 26, 16:00
63.47
0.00 (0.00%)
Pre-Market: 20:00
Cytokinetics Free Cash Flow : -534.82M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Bristol Myers Squibb Co. | 12.84B |
| Lifecore Biomedical, Inc. | 2.628M |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| Corcept Therapeutics, Inc. | 141.78M |
| Insmed, Inc. | -997.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -142.65M |
| Cash from Investing (Quarterly) | -71.19M |
| Cash from Financing (Quarterly) | 110.70M |
| Free Cash Flow Per Share (Quarterly) | -1.211 |
| Free Cash Flow to Equity (Quarterly) | -235.68M |
| Free Cash Flow to Firm (Quarterly) | -117.96M |
| Free Cash Flow Yield | -7.02% |